Thursday, May 7, 2026

1:05 PM - 1:40 PM

118A

---

Speaker(s)

Dr. Neta Gotlieb

---

Session Details

By the end of this session, participants should be able to: 1. Describe the causes and epidemiology of Metabolic Dysfunction-Associated Steatotic Liver Disease (MAFLD) 2. Outline the investigation, early treatment options for MAFLD/ NAFLD (Non-Alcoholic Fatty Liver Disease). 3. Discuss risks for and prevention strategies of liver cirrhosis

---

Speaker